New Jersey vs Utah on USAspending: $8.1B vs $4.1B

Forty-four New Jersey awards for each Utah award

These figures are USAspending.gov obligations, not Treasury outlays. New Jersey’s $8.1B stock sits about $4.0 billion above Utah’s $4.1B. Place of performance in the award file is the scoring rule. New Jersey has more people (9,500,851 versus 3,503,613) and a file that is in a different paperwork class. Utah still posts the higher per-capita reading.

New Jersey’s $8,084,032,234 is spread across 1,162,765 records. Utah’s $4,062,080,272 sits on 26,509. That is about 44 New Jersey awards for each Utah award. Dollars favor New Jersey; paperwork volume favors New Jersey as well. Intensity and typical booking size do not. Utah’s thinner file on a $4.1B stock is a heavy book.

Utah’s 26,509 awards on $4,062,080,272 versus New Jersey’s 1,162,765 awards on $8,084,032,234 is a 44-to-1 paperwork gulf. People of 3,503,613 versus 9,500,851 produce $199.06 versus $92.49. FY2026 of $697,424,439 versus $878,702,039 is closer than the stacked ranking. Nonferrous metal rolling, drawing, and extruding versus pharmaceuticals is mix. A thin file on $4.1B is a heavy typical booking.

Utah’s $199.06 versus New Jersey’s $92.49

New Jersey’s 9,500,851 residents against $8.1B produce $92.49 per capita. Utah’s 3,503,613 residents against $4.1B produce $199.06. Intensity in Utah is more than double New Jersey’s even though New Jersey holds the larger stacked total and the million-row file.

A $199.06 per-person reading is an intensity fact attached to $4.1B, not a household payment. New Jersey’s $92.49 is attached to $8.1B. This table scores USAspending place of performance, not GDP. A 26,509-award file on $4.1B is consistent with a much heavier typical booking than a 1,162,765-award file on $8.1B.

Pharmaceuticals in New Jersey, nonferrous metals in Utah

New Jersey’s top industry is pharmaceutical preparation manufacturing. Utah’s is nonferrous metal (except copper and aluminum) rolling, drawing, and extruding. Those NAICS labels mark the largest grouping in each state’s file. Drug-manufacturing awards and specialty-metal awards are different lead products sitting on $8.1B and $4.1B stocks.

A pharmaceutical-preparation lead inside New Jersey’s 1,162,765-award file can sit among many smaller actions. A nonferrous-metal lead inside Utah’s 26,509-award file can concentrate rolling and drawing work without making Utah a single-product state. Mix and scale both differ. Neither label is the entire stock.

FY2026: $878.7M in New Jersey vs $697.4M in Utah

FY2026 obligations are $878,702,039 in New Jersey and $697,424,439 in Utah. New Jersey remains ahead in the latest year, but the recency gap is smaller than the stacked gap. Recency questions belong in FY2026. The $8.1B and $4.1B totals remain the full USAspending.gov aggregate this comparison uses. Both years are obligations, not outlays.

Do not divide those FY figures by New Jersey’s 1,162,765 or Utah’s 26,509 all-years awards. Per capita of $92.49 on 9,500,851 residents versus $199.06 on 3,503,613 residents is the intensity comparison. FY2026 answers how the latest year booked. Stacked totals still favor New Jersey.

A paperwork gulf with a quieter latest year

New Jersey leads stacked dollars ($8.1B vs $4.1B), award count (1,162,765 vs 26,509), population (9,500,851 vs 3,503,613), and FY2026 ($878.7M vs $697.4M). Utah leads per capita ($199.06 vs $92.49). The distinctive facts are the 44-to-1 row gap and Utah’s specialty-metal lead.

Pharmaceutical preparation manufacturing versus nonferrous metal (except copper and aluminum) rolling, drawing, and extruding is mix inside files that contain many other industries. Use the New Jersey and Utah hubs for agencies and recipients. Keep both stocks labeled as USAspending.gov obligations.

A 44-to-1 paperwork gulf on a specialty-metal file

Utah’s 26,509 awards on $4,062,080,272 versus New Jersey’s 1,162,765 awards on $8,084,032,234 is the most lopsided row split in this batch. Per capita of $199.06 on 3,503,613 residents versus $92.49 on 9,500,851 residents is the intensity inversion. FY2026 of $697,424,439 versus $878,702,039 is closer than the stacked ranking.

Nonferrous metal (except copper and aluminum) rolling, drawing, and extruding versus pharmaceutical preparation manufacturing is mix. Utah’s thin file on a $4.1B stock is a heavy typical booking. Both stocks are USAspending.gov obligations by place of performance, not outlays. Open the state hubs for the rest of the mix.

Questions

Which state has more federal spending, New Jersey or Utah?

New Jersey leads in stacked USAspending.gov obligations: $8,084,032,234 versus Utah’s $4,062,080,272. New Jersey has far more awards (1,162,765 vs 26,509) and more people (9,500,851 vs 3,503,613). Spending per capita is $92.49 in New Jersey and $199.06 in Utah. FY2026 obligations are $878.7M and $697.4M. These are obligations, not Treasury outlays.

Why does Utah have so few awards compared with New Jersey?

Utah logs 26,509 awards on $4.1B. New Jersey logs 1,162,765 awards on $8.1B. Utah’s thinner file on a still-large stock implies a much heavier typical booking. Per capita is $199.06 versus $92.49. Populations are 3,503,613 and 9,500,851. FY2026 is $697.4M versus $878.7M.

What industries lead New Jersey and Utah federal awards?

New Jersey’s top industry is pharmaceutical preparation manufacturing. Utah’s is nonferrous metal (except copper and aluminum) rolling, drawing, and extruding. Those slices sit on $8.1B and $4.1B obligation stocks. They mark the largest grouping in each file, not every award in either state. Award counts are 1,162,765 in New Jersey and 26,509 in Utah.

Are New Jersey vs Utah figures Treasury outlays?

No. SpendingVault uses USAspending.gov obligations. Outlays are cash payments and can lag. The $8.1B and $4.1B stacked totals and FY2026 amounts of $878.7M and $697.4M measure award commitments by place of performance, not Monthly Treasury Statement payments.